1-Isopropylhydrazine hydrochloride → 9-Bromo-2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-1,10b-diaza-benzo[e]azulene

HRID 1799898ノート

反応式

HRID 1799898 の反応式
C[N:2](C)[CH:3]=[N:4][C:5]([C:7]1[CH:8]=[C:9]2[N:15]([N:16]=1)[C:14]1[CH:17]=[C:18]([Br:21])[CH:19]=[CH:20][C:13]=1[O:12][CH2:11][CH2:10]2)=O.Cl.[CH:24]([NH:27]N)([CH3:26])[CH3:25]>C(O)(=O)C>[Br:21][C:18]1[CH:19]=[CH:20][C:13]2[O:12][CH2:11][CH2:10][C:9]3[N:15]([N:16]=[C:7]([C:5]4[N:27]([CH:24]([CH3:26])[CH3:25])[N:2]=[CH:3][N:4]=4)[CH:8]=3)[C:14]=2[CH:17]=1

参加物

4

反応物 2

HCID 855731-Isopropylhydrazine hydrochlorideHCID 582044179-Bromo-4,5-dihydro-6-oxa-1,10b-diaza-benzo[e]azulene-2-carboxylic acid 1-dimethylaminomethylideneamide

生成物 1

HCID 582047309-Bromo-2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-1,10b-diaza-benzo[e]azulene収率 76%

試薬・触媒・溶媒 1

HCID 176Acetic Acid溶媒

反応条件

温度
110 °C

実験手順

A mixture of 9-bromo-4,5-dihydro-6-oxa-1,10b-diaza-benzo[e]azulene-2-carboxylic acid 1-dimethylaminomethylideneamide (1.27 g, 3.5 mmol), isopropylhydrazine hydrochloride (0.48 g, 4.37 mmol) and glacial acetic acid (6 mL) was heated at 110° C. for 6.5 h, then cooled and concentrated in vacuo. The resultant residue was dissolved in aqueous sodium bicarbonate and DCM and the phases were separated. The aqueous phase was extracted several times with DCM, the combined organic extracts dried (MgSO4) and concentrated in vacuo. The resultant residue was subjected to flash chromatography (SiO2, gradient 30 to 70% ethyl acetate in cyclohexane) to give 9-Bromo-2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-1,10b-diaza-benzo[e]azulene (0.99 g, 76%). LCMS: RT=5.07 min, M+H+=374/376. 1H NMR δ (ppm) (CDCl3): 8.07 (1H, d, J=2.41 Hz), 7.96 (1H, s), 7.39 (1H, dd, J=8.63, 2.43 Hz), 7.08 (1H, d, J=8.63 Hz), 6.91 (1H, s), 5.73-5.65 (1H, m), 4.53 (2H, t, J=5.91 Hz), 3.18 (2H, t, J=5.91 Hz), 1.60 (6H, d, J=6.62 Hz)

後処理

  1. temperaturecooled
  2. concentrationconcentrated in vacuo
  3. dissolutionThe resultant residue was dissolved in aqueous sodium bicarbonate
  4. customDCM and the phases were separated
  5. extractionThe aqueous phase was extracted several times with DCM
  6. dry with materialthe combined organic extracts dried (MgSO4)
  7. concentrationconcentrated in vacuo

出典と根拠

ORDレコード
ord-f313dbf4d41a4886be7bd5c245aac4a9
出典データセット
uspto-grants-2013_01
特許番号
US08343955B2

反応ノート

読み込み中…